The report “Biomarkers Market by Product (Consumables, Services), by Type (Predictive, Pharmacodynamic, Safety), Application (Diagnostics, Drug Discovery, Personalized Medicine), Disease Indication (Cardiovascular, Immunological) – Global Forecast to 2020” report provides a detailed overview of the major drivers, restraints, opportunities, and challenges impacting the global biomarkers market along with the estimates and forecasts of the revenue and market share analysis.
The global biomarkers market will be valued at $24.10 Billion in 2015. It is expected to grow at a CAGR of 13.58% to reach $45.55 Billion by 2020. Increasing healthcare and R&D expenditure are the key growth drivers in this market. However, poorly suited regulatory & reimbursement systems, high cost of tests and sample collection & storage may hinder the growth of this market.
The global biomarkers market is segmented on the basis of product, type of biomarker, application, and disease indication. On the basis of application, the market is segmented into diagnostics development, drug discovery and development, personalized medicine, disease risk assessment, and others. Of these, diagnostics development accounted for the largest share of the global biomarkers market in 2015. On the other hand, personalized medicine is expected to grow at the highest rate.
Download PDF Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=43
By product, the market is divided into consumables, services, and software. Of these, consumables accounted for the largest share and are expected to show the highest growth. On the basis of type, the biomarkers market is categorized into safety biomarkers, efficacy biomarkers, and validation biomarkers. On the basis of disease indications, the biomarkers market is categorized into cancer, cardiovascular disorders, neurological disorders, immunological disorders, and other diseases.
The geographic segments included in this report are North America, Europe, Asia, and the Rest of the World (RoW).
The major players in this market include QIAGEN N.V. (Netherlands), PerkinElmer, Inc. (U.S.), Merck & Co, Inc. (U.S.), Bio-Rad Laboratories (U.S.), Enzo Biochem (U.S.), EKF Diagnostics Holdings plc (U.S.), Meso Scale Diagnostics, LLC (U.S.), Singulex, Inc. (U.S.), BioSims Technologies (France), Cisbio Bioassays (France), and Signosis, Inc. (U.S.).
Company Name: MarketsandMarkets
Contact Person: Rohan
Email: Send Email
Address:701 Pike Street, Suite 2175
Country: United States